Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
This trial is available at multiple Sutter Locations. Pleasecontact one of the following about Study N0577
SanFrancisco: ClinicalResearch@sutterhealth.org
PaloAlto/Santa Cruz: Tanya Pozniansky pozniat@sutterhealth.org
PAMF/Fremont:Tanya Pozniansky pozniat@sutterhealth.org
EastBay: Vivian Leong, RN Leongv@sutterhealth.org
Sacramento: SIMR@sutterhealth.org
Modesto: Stephanie Edmondson edmondsons@sutterhealth.org
Solano-VallejoCancer Center: Stephanie Gonzales gonzals1@sutterhealth.org
SanMateo: Stephanie Casal CasalSL@sutterhealth.org andBonnie Chan ChanBW@sutterhealth.org